InflaRx (IFRX) Preferred Shares (2016 - 2017)

InflaRx's (IFRX) quarterly Preferred Shares came in at $67.5 million in Q3 2017, up 16.95% quarter-over-quarter from $57.7 million in Q4 2016.

InflaRx (IFRX) Preferred Shares (2016 - 2017) Analysis & Trends

InflaRx has disclosed Preferred Shares across 2 years of filings, most recently posting $67.5 million for Q3 2017.

Preferred Shares for Q3 2017 came in at $67.5 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2017 was $67.5 million (changed N/A YoY), and the FY2016 annual result was $59.2 million, changed N/A from the prior year.
Preferred Shares came in at $67.5 million for Q3 2017 at InflaRx, up from $57.7 million in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $67.5 million in Q3 2017 to a low of $57.7 million in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-	-
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-	-
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-	-
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-	-
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-	-
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn	-
9	Abivax	94.26 Bn	94.26 Bn	-	-
10	InflaRx	764.68 Mn	764.68 Mn	10,877.40	-

Download Data

Date	Value
Sep 30, 2017	67.48 Mn
Dec 31, 2016	57.70 Mn